TotalMarketCap

Satellos Bioscience

MSLENasdaq CanadaHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$135.785 M

$6.40 -1.08%

Close of 6 Nov 2026

As of 6 Nov 2026, Satellos Bioscience (MSLE) has a market capitalization of $135.8M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

15,458,903

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #268Nervgen PharmaNGEN$141.0M
  2. #269Veraxa Biotech AG - Post de-SPACVRXA$139.4M
  3. #270Satellos BioscienceMSLE$135.8M
  4. #271AdageneADAG$133.4M
  5. #272Organigram GlobalOGI$132.3M

What if Satellos Bioscience were worth as much as…

Open the what-if tool →

Gold $28.2T

$1,330,896

Per share 207,952× higher

Bitcoin $1.53T

$72,012.46

Per share 11,252× higher

Apple $5.02T

$236,410.20

Per share 36,939× higher

Or at a round number

$200.0M$500.0M$1.00B$2.00B

Where these numbers come from

Share counts and financials for Satellos Bioscience are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.